Clinical Predictors of Fluoroquinolone‐Resistant Escherichia coli in Transrectal Ultrasound‐Guided Prostate Biopsy: Insights for Tailored Prophylaxis

Documenti analoghi

• Impact of the COVID ‐19 Pandemic on Prostate Cancer: Perturbations in Screening and Diagnostic Patterns
  di: Takahide Noro, et al.
  Pubblicazione: (2025)
• Development, Validation, and Clinical Utility of a Nomogram for Urological Tumors: How to Build the Best Predictive Model
  di: Takanobu Utsumi, et al.
  Pubblicazione: (2025)
• Hemorrhagic Risk of Transrectal Ultrasound‐Guided Prostate Biopsy Under Continued Antithrombotic Therapy
  di: Naoki Akagi, et al.
  Pubblicazione: (2026)
• Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin
  di: Ahmet Yıldırım Balık, et al.
  Pubblicazione: (2026)
• Editorial Comment on Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin
  di: Takanori Sekito, et al.
  Pubblicazione: (2026)